GWP
AZN icon

Gateway Wealth Partners’s AstraZeneca AZN Stock Holding History

Gateway Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
6,327
-1,106
-15% -$208K 0.07% 272
2026
Q1 		$1.47M Buy
+7,433
New +$1.43M 0.06% 308

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gateway Wealth Partners's AZN Position: Q2 2026 in Review

Gateway Wealth Partners reduced its AstraZeneca (AZN) stake by 15% in Q2 2026, selling an estimated $208K and leaving 6,327 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #272.

Gateway Wealth Partners first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.47M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Gateway Wealth Partners held 6,327 shares of AstraZeneca worth $1.2M as of Q2 2026.
  • Gateway Wealth Partners sold 1,106 AstraZeneca shares in Q2 2026, an estimated $208K.
  • AstraZeneca made up 0.07% of Gateway Wealth Partners's portfolio in Q2 2026, its #272 holding.
  • Gateway Wealth Partners first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Gateway Wealth Partners's AstraZeneca position peaked at $1.47M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.